Clinical Effectiveness and Cost-Effectiveness of Antiviral Combination Therapy with Peginterveron Alfa-2B and Ribavitin for Chronic Hepatitic C Administered according to the new genotype-specific guidelines
In: Value in Health, Vol. 7 (2004), No. 6, p. 759
2004abstract in journal
EconomicsFaculty of Business Administration and Economics » Business Administration » Health Care Management
Related: 1 publication(s)
Title in English:
Clinical Effectiveness and Cost-Effectiveness of Antiviral Combination Therapy with Peginterveron Alfa-2B and Ribavitin for Chronic Hepatitic C Administered according to the new genotype-specific guidelines
Author:
Wasem, JürgenUDE
- GND
- 110790677
- LSF ID
- 5214
- ORCID
- 0000-0001-9653-168X
- Other
- connected with university
Year of publication:
2004
Language of text:
English